Biomedical research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
Click here to see hierarchical division and subunit overview
Summary of publications:
Publications (original articles or review articles) published in 2020 from OUS - Dept. of Gastroenterology (Div Medicine)
31 publications found
CD4+ T cells persist for years in the human small intestine and display a TH1 cytokine profile
Mucosal Immunol
DOI 10.1038/s41385-020-0315-5, PubMed 32572129
Perioperative Microcirculatory Changes Detected with Gastroscopy Assisted Laser Doppler Flowmetry and Visible Light Spectroscopy in Patients with Median Arcuate Ligament Syndrome
Vasc Health Risk Manag, 16, 331-341
DOI 10.2147/VHRM.S252192, PubMed 32982262
Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial
Eur J Nutr, 59 (7), 3325-3338
DOI 10.1007/s00394-020-02282-5, PubMed 32440730
Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
Neurogastroenterol Motil, 33 (2), e13983
DOI 10.1111/nmo.13983, PubMed 32945066
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
PLoS One, 15 (5), e0232739
DOI 10.1371/journal.pone.0232739, PubMed 32437393
Experiences of managing a gluten-free diet on multiple levels of society: a qualitative study
BMC Nutr, 6 (1), 65
DOI 10.1186/s40795-020-00390-3, PubMed 33292694
Outcome after endoscopic treatment for dysplasia and superficial esophageal cancer - a cohort study
Scand J Gastroenterol, 55 (9), 1132-1138
DOI 10.1080/00365521.2020.1800813, PubMed 32748653
Effect of gender on mortality and causes of death in cirrhotic patients with gastroesophageal varices. A retrospective study in Norway
PLoS One, 15 (3), e0230263
DOI 10.1371/journal.pone.0230263, PubMed 32163489
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
Clin Gastroenterol Hepatol, 18 (10), 2295-2304.e2
DOI 10.1016/j.cgh.2020.02.014, PubMed 32068151
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials
BioDrugs, 34 (5), 681-694
DOI 10.1007/s40259-020-00438-7, PubMed 32965617
A Short Series of Laparoscopic Mesenteric Bypasses for Chronic Mesenteric Ischemia
Vasc Health Risk Manag, 16, 87-97
DOI 10.2147/VHRM.S243264, PubMed 32256075
Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study
BMJ Open Gastroenterol, 7 (1), e000361
DOI 10.1136/bmjgast-2019-000361, PubMed 32337058
Association of Childbearing With a Short-Term Reduced Risk of Crohn Disease in Mothers
Am J Epidemiol, 189 (4), 294-304
DOI 10.1093/aje/kwz285, PubMed 31907543
Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study
Scand J Gastroenterol, 55 (4), 436-441
DOI 10.1080/00365521.2020.1745879, PubMed 32252542
Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis
Gastroenterology (in press)
DOI 10.1053/j.gastro.2020.12.058, PubMed 33387530
Erosive Esophagitis and Symptoms of Gastroesophageal Reflux Disease in Patients with Morbid Obesity with and without Type 2 Diabetes: a Cross-sectional Study
Obes Surg, 30 (7), 2667-2675
DOI 10.1007/s11695-020-04545-w, PubMed 32193740
HIV-infected immunological non-responders have colon-restricted gut mucosal immune dysfunction
J Infect Dis (in press)
DOI 10.1093/infdis/jiaa714, PubMed 33216130
Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs
Trials, 21 (1), 524
DOI 10.1186/s13063-020-04434-8, PubMed 32539853
Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study
J Crohns Colitis (in press)
DOI 10.1093/ecco-jcc/jjaa232, PubMed 33367569
Pain and aetiological risk factors determine quality of life in patients with chronic pancreatitis, but a brick in the puzzle is missing
Pancreatology, 20 (7), 1347-1353
DOI 10.1016/j.pan.2020.09.004, PubMed 32948428
Multiple risk factors for diabetes mellitus in patients with chronic pancreatitis: A multicentre study of 1117 cases
United European Gastroenterol J, 8 (4), 453-461
DOI 10.1177/2050640620901973, PubMed 32213024
Self-esteem in patients with inflammatory bowel disease
Qual Life Res, 29 (7), 1839-1846
DOI 10.1007/s11136-020-02467-9, PubMed 32144613
The Impact of Spondyloarthritis and Joint Symptoms on Health-Related Quality of Life and Fatigue in IBD Patients. Results From a Population-Based Inception Cohort (20-Year Follow-up in the Ibsen Study)
Inflamm Bowel Dis, 26 (1), 114-124
DOI 10.1093/ibd/izz105, PubMed 31127829
Laser Doppler Flowmetry and Visible Light Spectroscopy of the Gastric Tube During Minimally Invasive Esophagectomy
Vasc Health Risk Manag, 16, 497-505
DOI 10.2147/VHRM.S269138, PubMed 33273819
A man in his 50s with chronic diarrhea and weight loss
Tidsskr. Nor. Laegeforen., 140 (11), 1148-1151
Recent Progress and Recommendations on Celiac Disease From the Working Group on Prolamin Analysis and Toxicity
Front Nutr, 7, 29
DOI 10.3389/fnut.2020.00029, PubMed 32258047
Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours
Health Qual Life Outcomes, 18 (1), 188
DOI 10.1186/s12955-020-01452-7, PubMed 32546236
Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease
BMC Cancer, 20 (1), 466
DOI 10.1186/s12885-020-06963-6, PubMed 32448245
A molecular basis for the T cell response in HLA-DQ2.2 mediated celiac disease
Proc Natl Acad Sci U S A, 117 (6), 3063-3073
DOI 10.1073/pnas.1914308117, PubMed 31974305
Patient reported exposure to smoking and alcohol abuse are associated with pain and other complications in patients with chronic pancreatitis
Pancreatology, 20 (5), 844-851
DOI 10.1016/j.pan.2020.05.001, PubMed 32507681
Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease
JHEP Rep, 3 (1), 100178
DOI 10.1016/j.jhepr.2020.100178, PubMed 33225252